Detalhe da pesquisa
1.
Leishmania (L.) amazonensis LaLRR17 increases parasite entry in macrophage by a mechanism dependent on GRP78.
Parasitology
; 150(10): 922-933, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553284
2.
Repurposing topical triclosan for cutaneous leishmaniasis: Preclinical efficacy in a murine Leishmania (L.) amazonensis model.
Drug Dev Res
; 83(2): 285-295, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767443
3.
Increasing the activity of copper(II) complexes against Leishmania through lipophilicity and pro-oxidant ability.
J Biol Inorg Chem
; 17(1): 107-12, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21866394
4.
Synthesis, characterization and evaluation of antileishmanial activity of copper(II) with fluorinated α-hydroxycarboxylate ligands.
Biometals
; 22(6): 1095-101, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19680603
5.
Promastigote parasites cultured from the lesions of patients with mucosal leishmaniasis are more resistant to oxidative stress than promastigotes from a cutaneous lesion.
Free Radic Biol Med
; 129: 35-45, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196081
6.
Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection.
Am J Trop Med Hyg
; 99(5): 1165-1169, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203744
7.
New iminodibenzyl derivatives with anti-leishmanial activity.
J Inorg Biochem
; 172: 9-15, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28414928
8.
Leishmania metacyclogenesis is promoted in the absence of purines.
PLoS Negl Trop Dis
; 6(9): e1833, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23050028
9.
Repurposing for neglected diseases.
Science
; 326(5955): 935; author reply 935, 2009 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965498
10.
Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine.
Vaccine
; 20(31-32): 3755-63, 2002 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12399206